WO1998036732A3 - Preparation combinee pour antibiotiques administrables par voie orale - Google Patents
Preparation combinee pour antibiotiques administrables par voie orale Download PDFInfo
- Publication number
- WO1998036732A3 WO1998036732A3 PCT/EP1998/000029 EP9800029W WO9836732A3 WO 1998036732 A3 WO1998036732 A3 WO 1998036732A3 EP 9800029 W EP9800029 W EP 9800029W WO 9836732 A3 WO9836732 A3 WO 9836732A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- component
- orally administered
- combination preparation
- administered antibiotics
- antibiotics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU60926/98A AU6092698A (en) | 1997-02-21 | 1998-01-05 | Combination preparation for orally administered antibiotics |
EP98905269A EP0971691A2 (fr) | 1997-02-21 | 1998-01-05 | Preparation combinee pour antibiotiques administrables par voie orale |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19706978.9 | 1997-02-21 | ||
DE1997106978 DE19706978A1 (de) | 1997-02-21 | 1997-02-21 | Kombinationspräparat für oral applizierbare Antibiotika |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998036732A2 WO1998036732A2 (fr) | 1998-08-27 |
WO1998036732A3 true WO1998036732A3 (fr) | 1998-10-22 |
Family
ID=7821094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/000029 WO1998036732A2 (fr) | 1997-02-21 | 1998-01-05 | Preparation combinee pour antibiotiques administrables par voie orale |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0971691A2 (fr) |
AU (1) | AU6092698A (fr) |
DE (1) | DE19706978A1 (fr) |
WO (1) | WO1998036732A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6551616B1 (en) | 1997-04-11 | 2003-04-22 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
GB9815532D0 (en) * | 1998-07-17 | 1998-09-16 | Lek Pharmaceutical & Cvhemical | Pharmaceutical suspension formulation |
GB9930578D0 (en) * | 1999-12-23 | 2000-02-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
WO2003053399A2 (fr) * | 2001-12-21 | 2003-07-03 | Pfizer Products Inc. | Procedes de granulation par voie humide d'azithromycine |
JP2014521714A (ja) | 2011-08-12 | 2014-08-28 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネコ科動物の心不全を治療および予防する方法において使用するための奇異性電流(If)阻害薬 |
WO2014122248A1 (fr) | 2013-02-11 | 2014-08-14 | Boehringer Ingelheim Vetmedica Gmbh | Kit d'éléments |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0069097A2 (fr) * | 1981-06-18 | 1983-01-05 | Astra Läkemedel Aktiebolag | Mélange pharmaceutique |
GB2122490A (en) * | 1982-06-24 | 1984-01-18 | Astra Laekemedel Ab | Controlled release formulation |
WO1993000898A1 (fr) * | 1991-07-11 | 1993-01-21 | Smithkline Beecham Plc | Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau |
EP0551820A1 (fr) * | 1992-01-15 | 1993-07-21 | Bayer Ag | Compositions pharmaceutiques masquant le mauvais goût |
WO1993017667A1 (fr) * | 1992-03-12 | 1993-09-16 | Taisho Pharmaceutical Co., Ltd. | Composition pour preparations buvables |
WO1996001628A1 (fr) * | 1994-07-07 | 1996-01-25 | Recordati Industria Chimica E Farmaceutica S.P.A. | Composition pharmaceutique pour la liberation regulee de moguisteine sous forme de suspension liquide |
-
1997
- 1997-02-21 DE DE1997106978 patent/DE19706978A1/de not_active Withdrawn
-
1998
- 1998-01-05 AU AU60926/98A patent/AU6092698A/en not_active Abandoned
- 1998-01-05 EP EP98905269A patent/EP0971691A2/fr not_active Withdrawn
- 1998-01-05 WO PCT/EP1998/000029 patent/WO1998036732A2/fr not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0069097A2 (fr) * | 1981-06-18 | 1983-01-05 | Astra Läkemedel Aktiebolag | Mélange pharmaceutique |
GB2122490A (en) * | 1982-06-24 | 1984-01-18 | Astra Laekemedel Ab | Controlled release formulation |
WO1993000898A1 (fr) * | 1991-07-11 | 1993-01-21 | Smithkline Beecham Plc | Formulation pharmaceutique comprenant une beta-lactamine et de l'acide clavulanique ou un sel de celui-ci soluble dans l'eau |
EP0551820A1 (fr) * | 1992-01-15 | 1993-07-21 | Bayer Ag | Compositions pharmaceutiques masquant le mauvais goût |
WO1993017667A1 (fr) * | 1992-03-12 | 1993-09-16 | Taisho Pharmaceutical Co., Ltd. | Composition pour preparations buvables |
WO1996001628A1 (fr) * | 1994-07-07 | 1996-01-25 | Recordati Industria Chimica E Farmaceutica S.P.A. | Composition pharmaceutique pour la liberation regulee de moguisteine sous forme de suspension liquide |
Also Published As
Publication number | Publication date |
---|---|
AU6092698A (en) | 1998-09-09 |
EP0971691A2 (fr) | 2000-01-19 |
DE19706978A1 (de) | 1998-08-27 |
WO1998036732A2 (fr) | 1998-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2251886A1 (fr) | Preparation pharmaceutique orale contenant de l'ibandronate | |
CA2225960A1 (fr) | Compositions pharmaceutiques | |
CA2253811A1 (fr) | Suspensions liquides a gout masque | |
CA2193337A1 (fr) | Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs | |
CA2163706A1 (fr) | Derives amino-acides de paclitaxel | |
CA2170622A1 (fr) | Formulations orales pour un antifongique | |
CA2258095A1 (fr) | Compositions contenant de la tetrahydrolipstatine | |
CA2203033A1 (fr) | Composes et compositions pour l'administration d'agents actifs | |
CA2337046A1 (fr) | Preparation pharmaceutique a liberation prolongee | |
IE881452L (en) | Pharmaceutical composition | |
EP1731140A3 (fr) | Formulation d'aerosol medicinal | |
CA2024631A1 (fr) | Granules a double enrobage | |
HUP9800813A3 (en) | Lactam-containing hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them | |
WO2001027109A3 (fr) | Derives de tert.-butyl-(methyl-imidazo[1,2-a]pyridine-3-yl)amine | |
AU3345197A (en) | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof | |
AU2002238947A1 (en) | Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient | |
AU5651696A (en) | Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them | |
CA2292673A1 (fr) | Compositions pharmaceutiques contenant hemisulfate d'eletriptane | |
CA2164776A1 (fr) | Composition pharmaceutique, administrable par voie orale | |
CA2175971A1 (fr) | Composition liquide stable renfermant de l'urate-oxydase; composition lyophilisee pour sa preparation | |
CA2338794A1 (fr) | Nouvelle formulation orale d'agonistes ou d'antagonistes de 5-ht4 | |
AU7694896A (en) | Prompt-release pharmaceutical compositions | |
CA2376894A1 (fr) | Composition pharmaceutique comprenant une proteine et une ectoine | |
AU7306096A (en) | Aryl-piperazine cyclic amine derivatives, preparation thereof and pharmaceutical compositions containing same | |
WO1998036732A3 (fr) | Preparation combinee pour antibiotiques administrables par voie orale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998905269 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998905269 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998536182 Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998905269 Country of ref document: EP |